Diabetes mellitus type I
PDF (Español (España))
HTML (Español (España))
سرور مجازی ایران Decentralized Exchange

How to Cite

1.
Salazar Campos N, Sandí Ovares N, Mejía Arens C. Diabetes mellitus type I: challenges to achieve an optimal glycemic control. Rev.méd.sinerg. [Internet]. 2020Sep.1 [cited 2024Nov.22];5(9):e452. Available from: https://revistamedicasinergia.com/index.php/rms/article/view/452

Abstract

Type 1 diabetes mellitus is a disease, being a highly prevalent disease in the pediatric population, of complex autoimmune etiology, characterized by destruction of pancreatic beta cells in genetically predisposed individuals and the consequent deficiency in insulin production and hyperglycemia. The diagnosis is based on clinical features and laboratory findings. The key element of treatment for optimal glycemic control is an intensive multiple-dose insulin regimen. Despite this, most patients have suboptimal glycemic control, which has led to the investigation and identification of possible factors involved in suboptimal control of the disease.

https://doi.org/10.31434/rms.v5i9.452

Keywords

diabetes mellitus, type1. hyperglycemia. insulin. ketosis. etiology. goals.
PDF (Español (España))
HTML (Español (España))

References

Cooke D.W and Plotnick L. Type 1 Diabetes Mellitus in Pediatrics. Pediatr. Rev. 2008;29;374-385. [Internet]. 2008 [citado: 15 de febrero 2020]; 29: 374-385. https://doi.org/10.1542/pir.29-11-374

Noble JA. Immunogenetics of type 1 diabetes: A comprehensive review. Journal of Autoimmunity [Internet]. 2015 [citado: 15 de febrero 2020]; 64: 101-112. https://doi.org/10.1016/j.jaut.2015.07.014

Wolfsdorf, JI. Allgrove, J. Craig, ME. Edge J, Glaser N, Jain V, et.al. ISPAD Clinical Practice Consensus Guidelines 2014 Compendium Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatric Diabetes [Internet]. 2014 [citado: 15 de febrero 2020]; 15(S20): 154-179. https://doi.org/10.1111/pedi.12165

Mamdouh Hassan M, Arafa N, Abdou M, Hussein O. Characteristics of diabetes diagnosis and control in toddlers and preschoolers from families with limited resources: A single center experience. Diabetes research and clinical practice. [Internet]. 2020 [citado: 15 de febrero 2020]; 159:107966. https://doi.org/10.1016/j.diabres.2019.107966

DiMeglio LA., Evans-Molina. C, Oram, RA.; Type 1 diabetes. TheLancet [Internet]. 2018 [citado: 15 de febrero 2020]; 391(10138): 2449-2462. https://doi.org/10.1016/S0140-6736(18)31320-5

Saberzadeh-Ardestani B, Karamzadeh R, Basiri M, Hajizadeh-Saffar E, Farhadi A, Shapiro AMJ, et al. Type 1 Diabetes Mellitus: Cellular and Molecular Pathophysiology at A Glance. Cell J [Internet]. 2018 [citado: 15 de febrero 2020]; 20(3): 294-301. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004986/pdf/Cell-J-20-294.pdf

Beck JK, Cogen FR. Outpatient Management of Pediatric Type 1 Diabetes. The Journal of Pediatric Pharmacology and Therapeutics [Internet]. 2015 [citado: 15 de febrero 2020]; 20(5): 344-357. Disponible en: https://www.jppt.org/doi/abs/10.5863/1551-6776-20.5.344

Hasanbegovic S, Obarcanin E, Hasanbegovic E, Begic N. Impact of Insulin Delivery Method on Hypoglycemia Incidence in Pediatric Type 1 Diabetes Mellitus Patients. MedArch [Internet]. 2017 [citado: 15 de febrero 2020]; 71(6): 391-395. https://doi.org/10.5455/medarh.2017.71.391-395

Langendam M, Luijf Y, Hooft L, DeVries J, Mudde A, Scholten R. Continuous glucose monitoring systems for type 1 diabetes mellitus. Cochrane Database Syst Rev. [Internet]. 2012 [citado: 15 de febrero 2020];18(1): 1-143. https://doi.org/10.1002/14651858.CD008101.pub2

Berget C, Driscoll K, Lagges A, Lange S, DiMeglio L, Hannon T, et al. Optimizing the use of continuous glucose monitoring in young children with type 1 diabetes with an adaptive study design and multiple randomizations, for the Toddler Diabetes Technology Study Group. Contemporary Clinical Trials [Internet]. 2019 [citado: 15 de febrero 2020]; 82: 60-65. https://doi.org/10.1016/j.cct.2019.05.008

Otto-Buczkowska E, Jainta N. Pharmacological Treatment in Diabetes Mellitus Type 1 - Insulin and What Else?.Int J EndocrinolMetab [Internet]. 2018 [citado: 15 de febrero 2020]; 16(1): e13008. https://doi.org/10.5812/ijem.13008

Zsori G, D Illes D, Terzin V, Ivany E, Czako L. Exocrine pancreatic insufficiency in type 1 and type 2 diabetes mellitus: do we need to treat it? A systematic review. Pancreatology [Internet]. 2018 [citado: 15 de febrero 2020]; 18(5): 559-565. https://doi.org/10.1016/j.pan.2018.05.006

Codner E, Acerini CL, Craig ME, Hofer SE, Maahs DM. ISPAD Clinical Practice Consensus Guidelines 2018: What is new in diabetes care? Pediatric Diabetes [Internet]. 2018 [citado: 15 de febrero 2020]; 19(S27): 5-6. https://doi.org/10.1111/pedi.12759

Chih AH, Jan CF, Shu SG, Lue BH. Self-efficacy Affects Blood Sugar Control Among Adolescents With Type I Diabetes Mellitus. Journal of the Formosan Medical Association [Internet]. 2010 [citado: 15 de febrero 2020]; 109(7): 503-510. Disponible en: https://doi.org/10.1016/S0929-6646(10)60084-8

Bolli G. The benefits of insulin analogues in intensive treatment of type 1 diabetes mellitus. Av Diabetol. [Internet]. 2007 [citado: 15 de febrero 2020]; 23 (5):326-332. Disponible en: http://avancesendiabetologia.org/revista/revista.asp?webRevista=5&idRevista=15&pa=revistasAnteriores

Heise T, Ho ̈velmann U, Zijlstra E, Stender-Petersen K, Jacobsen JB, Haahr H. A Comparison of Pharmacokinetic and Pharmacodynamic Properties Between Faster-Acting Insulin Aspart and Insulin Aspart in Elderly Subjects with Type 1 Diabetes Mellitus. Drugs Aging. DrugsAging [Internet]. 2017 [citado: 15 de febrero 2020]; 34: 29-38. https://doi.org/10.1007/s40266-016-0418-6

Garg V. Noninsulin pharmacological management of type 1 diabetes mellitus. Indian J Endocr Metab. [Internet]. 2011[citado: 15 de febrero 2020];15:S5-11. https://doi.org/10.4103/2230-8210.83053

Domouky AM, Hegab AS, Al-Shahat A, Raafat N. Mesenchymal stem cells and differentiated insulin producing cells are new horizons for pancreatic regeneration in type I diabetes mellitus. International Journal of Biochemistry &CellBiology [Internet]. 2017 [citado: 15 de febrero 2020]; 87: 77-85. https://doi.org/10.1016/j.biocel.2017.03.018

Health Quality Ontario. Pancreas islet transplantation for patients with type 1 diabetes mellitus: a clinical evidence review. OntHealthTechnolAssess Ser. [Internet]. 2015 [citado: 15 de febrero 2020]; 15(16): 1-84. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664938/pdf/ohtas-15-1.pdf

Amer MG, Embaby AS, Karam RA, Amer MG. Role of adipose tissue derived stem cells differentiated into insulin producing cells in the treatment of type I diabetes mellitus. Gene [Internet]. 2018 [citado: 15 de febrero 2020]; 654: 87-94. https://doi.org/10.1016/j.gene.2018.02.008

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2020 Array

Downloads

Download data is not yet available.
فروشگاه اینترنتی vpn for android خرید vpn سایت شرط بندی